Clinical and radiological results 7 years after Copeland shoulder resurfacing arthroplasty in patients with primary glenohumeral osteoarthritis: an independent multicentre retrospective study

Verstraelen, Freek; Horta, L. A.; Schotanus, Martijn G.M.; Kort, Nanne P.; Samijo, Steven K.; Jansen, E.J.

doi:10.1007/s00590-017-2023-8

Cited by 20 publications

(17 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…3 Recent studies have reported mixed results of CRHA with 5-year survival estimated as low as 79% 4 and as high as 97.5%. 5,6 These studies included relatively small numbers of patients and used strict inclusion and exclusion criteria therefore may not be representative of the entire population.…”

Section: Introductionmentioning

confidence: 99%

6-Year clinical results and survival of Copeland Resurfacing hemiarthroplasty of the shoulder in a consecutive series of 279 cases

Dekker

Joshi

Morgan

et al. 2020

Journal of Clinical Orthopaedics and Trauma

View full text Add to dashboard Cite

Background: Medium-term clinical results and survival of the Copeland resurfacing hemiarthroplasty of the shoulder (CRHA) in a large consecutive group are presented with a comparison of outcomes for underlying pathologies. Methods: A consecutive series of patients undergoing CRHA over 14 years was retrospectively analysed with no exclusions. Patients had a minimum 2-year follow-up by an independent assessor. Functional outcome was assessed using the Oxford Shoulder Score (OSS) and Constant-Murley Score (CMS). Pain and satisfaction was assessed using a visual analogue score. Results: 279 CRHAs were performed in 242 patients between 2002 and 2016. The mean follow-up was 6 years. The indication for surgery was osteoarthritis (OA) in 212, inflammatory arthropathy (RA) in 35, rotator cuff tear arthropathy (CTA) in 22 and avascular necrosis (AVN) in 2. For the OA group, 5-year survival was 90%, 10-year survival was 83% and mean survival was 13.2 years (95% CI 12.5e13.9). The mean OSS was 35.0 and mean CMS 49.9. CRHA for CTA had significantly poorer (p < 0.001) 5-year survival (55%), 10-year survival (41%) and mean survival (5.9 years, 95% CI 4.7e7.2). Mean OSS was 23.6 and mean CMS 30.3, which was poorer than for OA (p < 0.001). A subgroup analysis of OA patients found significantly better survival (p ¼ 0.013) in those aged over 65 years but no difference in functional outcome. Conclusion: CRHA remains a reasonable option for OA in patients with an intact rotator cuff and with sufficient bone stock, especially in those aged over 65 years. With poorer functional outcomes and survival, CRHA should not be offered in those with CTA.

show abstract

Section: Introductionmentioning

confidence: 99%

6-Year clinical results and survival of Copeland Resurfacing hemiarthroplasty of the shoulder in a consecutive series of 279 cases

Dekker

Joshi

Morgan

et al. 2020

Journal of Clinical Orthopaedics and Trauma

View full text Add to dashboard Cite

show abstract

“…Sweet et al 25 and Pritchett 31 reported 90% and 95% patient satisfaction with the procedure, respectively, compared to our 71.7% satisfaction with current symptoms, although definitions of satisfaction showing that despite poor radiographic outcomes at a mean of 7.2 years after HHR, clinical outcomes were good. 32 Our study has several limitations. First, patients were given the option of completing the PRO survey electronically or in paper form.…”

Section: Discussionmentioning

confidence: 91%

“…demonstrated a similar concept, showing that despite poor radiographic outcomes at a mean of 7.2 years after HHR, clinical outcomes were good. 32 …”

Section: Discussionmentioning

confidence: 99%

Preoperative Comorbidities and Postoperative Complications Do Not Influence Patient-Reported Satisfaction Following Humeral Head Resurfacing: Mid- to Long-term Follow-up of 106 Patients

Beck

Lee

Fourman

et al. 2019

Journal of Shoulder and Elbow Arthroplasty

View full text Add to dashboard Cite

Background: Humeral head resurfacing (HHR) has emerged as an alternative treatment for glenohumeral osteoarthritis. We investigated the outcomes of HHR using validated patient-reported outcome (PRO) measures. Methods: A retrospective review was performed on 213 patients who underwent HHR. A PRO follow-up was performed by administering a questionnaire including the American Shoulder and Elbow Society (ASES) score, Brophy activity survey, short form of the Disabilities of the Arm, Shoulder and Hand (quickDASH) survey, and general shoulder function. PRO scores were stratified by comorbidities and complications. Results: Survey responses were received from 106 patients (51%), with a mean follow-up of 5.6 AE 1.8 years (range: 9 months to 6.1 years). Preoperative comorbidities were associated with significantly higher quickDASH scores. Postoperative complications were associated with significantly higher rates of current pain, higher visual analog scale scores, night pain, lower subjective shoulder values, and lower ASES pain and total scores. No differences in patient satisfaction were identified between the cohorts with and without preoperative comorbidities and between the cohorts with and without postoperative complications. Conclusion: In our cross-sectional analysis of mid-to long-term outcomes following HHR, preoperative comorbidities, or postoperative complications had no impact on patient-perceived postoperative satisfaction or most PROs. HHR is clinically viable in a wide variety of patients. Future work is necessary to compare the efficacy of HHR compared with more traditional total shoulder arthroplasty and stemmed hemiarthroplasty regarding long-term outcomes and appropriate indications.

show abstract

“…Especially, RHA has been promoted as a bone-sparing alternative to SHA for over ten years among doctors and patients. Various types of resurfacing procedures have been described in terms of shortand mid-term clinical effectiveness by mounting studies [32,53,[57][58][59][60] and a recent systemic review [61] suggested that resurfacing replacements could provide a significant improvement in pain, motion, and standardized outcome scores.…”

Section: Discussionmentioning

confidence: 99%

“…1b), which is a less invasive humeral head surface replacement with minimal bone resection. Subsequently, some studies reported that RHA could provide recovery of pain-free functional motion and facilitate the revision to TSA or RSA despite high complication rate during long-term follow-ups [30][31][32][33][34][35][36][37].…”

Section: Introductionmentioning

confidence: 99%

Resurfacing hemiarthroplasty versus stemmed hemiarthroplasty for glenohumeral osteoarthritis: a meta-analysis

et al. 2020

View full text Add to dashboard Cite

Background: Though total shoulder arthroplasty (TSA) has been an acknowledged treatment option for glenohumeral osteoarthritis, resurfacing hemiarthroplasty (RHA) and stemmed hemiarthroplasty (SHA) may be preferred in some circumstances by surgeons, especially for treating young or active patients. However, decision-making between the RHA and SHA is controversial. Therefore, we conducted a meta-analysis to systematically compare two surgical procedures in terms of postoperative functional outcomes, range of motion (ROM), pain relief, complication rates, risk of revision. Methods: The PubMed, Embase, Web of Science and Cochrane Library were searched from inception to January 1, 2020, for all articles that compared the clinical effectiveness and safety of RHA with SHA. All eligible studies were selected based on certain screening criteria. Two investigators independently conducted the quality assessment and extracted the data. Fixed-effect and random-effect models were used for pooled results according to the degree of heterogeneity. All statistical analyses were performed by employing Stata software 14.0. Results: A total of six comparative studies involving 2568 shoulders (1356 RHA and 1212 SHA) were included in the final analysis. Patients were followed up for at least 1 year in each study. Pooled results showed that RHA was associated with a better visual analog scale (SMD 0.61, p = 0.001) but higher revision rates (OR 1.50, p = 0.016) when compared to SHA. There were no significant differences in functional outcomes, such as Constant-Murley score (SMD 0.06, P = 0.878), American Shoulder and Elbow Surgeons score (SMD 0.05, P = 0.880), Western Ontario Osteoarthritis of the Shoulder index (SMD 0.43, p = 0.258) and quick-Disabilities of the Arm, Shoulder and Hand score (SMD 0.06, p = 0.669). In addition, no differences were observed in forward flexion (SMD 0.16, p = 0.622), external rotation (SMD-0.17, P = 0.741) and overall complication rates (OR 1.42, p = 0.198).

show abstract

Clinical and radiological results 7 years after Copeland shoulder resurfacing arthroplasty in patients with primary glenohumeral osteoarthritis: an independent multicentre retrospective study

Abstract: For primary osteoarthritis, the CSRA showed good clinical but poor radiological outcomes at midterm follow-up.

Cited by 20 publications

References 40 publications

6-Year clinical results and survival of Copeland Resurfacing hemiarthroplasty of the shoulder in a consecutive series of 279 cases

6-Year clinical results and survival of Copeland Resurfacing hemiarthroplasty of the shoulder in a consecutive series of 279 cases

Preoperative Comorbidities and Postoperative Complications Do Not Influence Patient-Reported Satisfaction Following Humeral Head Resurfacing: Mid- to Long-term Follow-up of 106 Patients

Resurfacing hemiarthroplasty versus stemmed hemiarthroplasty for glenohumeral osteoarthritis: a meta-analysis

Contact Info

Product

Resources

About